scholarly journals Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

2016 ◽  
Vol 19 (7) ◽  
pp. A695-A696
Author(s):  
M Bourdoncle ◽  
J Li ◽  
A Berthelot ◽  
M Cognet ◽  
C Sambuc ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cost Effectiveness ◽  
Trisomy 21 ◽  
Cost Effectiveness Analysis ◽  
Cell Free Dna ◽  
Non Invasive ◽  
Free Dna ◽  
Effectiveness Analysis ◽  
Prenatal Test

Cell-Free DNA–Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis

2018 ◽  
Vol 40 (1) ◽  
pp. 48-60 ◽  
Author(s):  
Léon Nshimyumukiza ◽  
Jean-Alexandre Beaumont ◽  
Julie Duplantie ◽  
Sylvie Langlois ◽  
Julian Little ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Prenatal Screening ◽  
Cost Effectiveness Analysis ◽  
Canadian Province ◽  
Cell Free Dna ◽  
Non Invasive ◽  
Free Dna ◽  
Effectiveness Analysis

A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome

2015 ◽  
Vol 35 (5) ◽  
pp. 440-446 ◽  
Author(s):  
Brandon S. Walker ◽  
Brian R. Jackson ◽  
Danielle LaGrave ◽  
Edward R. Ashwood ◽  
Robert L. Schmidt
Keyword(s):  
Down Syndrome ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Cell Free Dna ◽  
Free Dna ◽  
Effectiveness Analysis ◽  
Serum Screening

Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review

2017 ◽  
Vol 19 (7) ◽  
pp. 979-991 ◽  
Author(s):  
Lidia García-Pérez ◽  
Renata Linertová ◽  
Margarita Álvarez-de-la-Rosa ◽  
Juan Carlos Bayón ◽  
Iñaki Imaz-Iglesia ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cost Effectiveness ◽  
Trisomy 21 ◽  
Maternal Blood ◽  
Blood Testing ◽  
Cell Free Dna ◽  
Prenatal Detection ◽  
Free Dna
Sign in / Sign up

Export Citation Format

Share Document